JP2020505334A5 - - Google Patents

Download PDF

Info

Publication number
JP2020505334A5
JP2020505334A5 JP2019537154A JP2019537154A JP2020505334A5 JP 2020505334 A5 JP2020505334 A5 JP 2020505334A5 JP 2019537154 A JP2019537154 A JP 2019537154A JP 2019537154 A JP2019537154 A JP 2019537154A JP 2020505334 A5 JP2020505334 A5 JP 2020505334A5
Authority
JP
Japan
Prior art keywords
seq
monoclonal antibody
antibody according
amino acid
chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019537154A
Other languages
English (en)
Japanese (ja)
Other versions
JP7128191B2 (ja
JP2020505334A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/012479 external-priority patent/WO2018129248A1/en
Publication of JP2020505334A publication Critical patent/JP2020505334A/ja
Publication of JP2020505334A5 publication Critical patent/JP2020505334A5/ja
Priority to JP2022130651A priority Critical patent/JP7461420B2/ja
Application granted granted Critical
Publication of JP7128191B2 publication Critical patent/JP7128191B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019537154A 2017-01-06 2018-01-05 治療抗ＩｇＥ抗体並びにその方法及び組成物 Active JP7128191B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022130651A JP7461420B2 (ja) 2017-01-06 2022-08-18 治療抗ＩｇＥ抗体並びにその方法及び組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762443547P 2017-01-06 2017-01-06
US62/443,547 2017-01-06
PCT/US2018/012479 WO2018129248A1 (en) 2017-01-06 2018-01-05 Therapeutic anti-ige antibodies and methods and compositions thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022130651A Division JP7461420B2 (ja) 2017-01-06 2022-08-18 治療抗ＩｇＥ抗体並びにその方法及び組成物

Publications (3)

Publication Number Publication Date
JP2020505334A JP2020505334A (ja) 2020-02-20
JP2020505334A5 true JP2020505334A5 (https=) 2021-02-04
JP7128191B2 JP7128191B2 (ja) 2022-08-30

Family

ID=62789396

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019537154A Active JP7128191B2 (ja) 2017-01-06 2018-01-05 治療抗ＩｇＥ抗体並びにその方法及び組成物
JP2022130651A Active JP7461420B2 (ja) 2017-01-06 2022-08-18 治療抗ＩｇＥ抗体並びにその方法及び組成物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022130651A Active JP7461420B2 (ja) 2017-01-06 2022-08-18 治療抗ＩｇＥ抗体並びにその方法及び組成物

Country Status (6)

Country Link
US (2) US11518818B2 (https=)
EP (1) EP3565587A4 (https=)
JP (2) JP7128191B2 (https=)
AU (1) AU2018205484B2 (https=)
CA (1) CA3049967C (https=)
WO (1) WO2018129248A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113474012B (zh) 2019-01-25 2023-09-08 湖南远泰生物技术有限公司 Epcam抗体和epcam-car-t细胞

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6685939B2 (en) 1991-08-14 2004-02-03 Genentech, Inc. Method of preventing the onset of allergic disorders
CA2113813C (en) * 1991-08-14 2005-04-12 Paula M. Jardieu Immunoglobulin variants for specific fc epsilon receptors
HK1048127A1 (en) 2000-01-14 2003-03-21 Daiichi Pharmaceutical Co., Ltd. Novel peptide and screening method by using the same
AU7658101A (en) 2000-07-28 2002-02-13 Cytos Biotechnology Ag Compositions for inducing self-specific anti-ige antibodies and uses thereof
SI2000481T1 (sl) * 2003-02-01 2016-08-31 Tanox, Inc. Anti-humana protitelesa IgE z visoko afiniteto
US20050169909A1 (en) * 2004-02-02 2005-08-04 Sanjaya Singh Identification of novel IgE epitopes
EP1718669A4 (en) * 2004-02-02 2007-10-10 Tanox Inc IDENTIFICATION OF NEW IGE EPITOPES
CN101203241B (zh) * 2005-04-19 2012-02-22 西雅图基因公司 人源化抗-cd70结合物和其应用
WO2008070593A2 (en) * 2006-12-01 2008-06-12 Seattle Genetics, Inc. Variant target binding agents and uses thereof
UY30994A1 (es) 2007-04-02 2008-11-28 Amgen Fremont Inc Anticuerpos anti-ige
CN101925611A (zh) * 2007-11-21 2010-12-22 安姆根有限公司 Wise结合剂和表位
US20130236467A1 (en) * 2010-11-24 2013-09-12 Jeremy Griggs Multispecific antigen binding proteins targeting hgf
KR20140119777A (ko) * 2012-01-31 2014-10-10 제넨테크, 인크. 항-ig-e m1'' 항체 및 그의 사용 방법
WO2013192594A2 (en) * 2012-06-21 2013-12-27 Sorrento Therapeutics Inc. Antigen binding proteins that bind c-met
WO2015195631A1 (en) 2014-06-17 2015-12-23 Academia Sinica HUMANIZED ANTI-IgE ANTIBODIES THAT CROSSLINK CD23 ON B LYMPHOCYTES BUT DO NOT SENSITIZE MAST CELLS
WO2017186928A1 (en) * 2016-04-29 2017-11-02 Curevac Ag Rna encoding an antibody
EP3448874A4 (en) 2016-04-29 2020-04-22 Voyager Therapeutics, Inc. COMPOSITIONS FOR TREATING A DISEASE
CA3089260A1 (en) * 2018-01-22 2019-07-25 Jiangsu Hengrui Medicine Co., Ltd. Anti-4-1bb antibody, antigen-binding fragment thereof and medical use thereof

Similar Documents

Publication Publication Date Title
JP2019520818A5 (https=)
JP2019529350A5 (https=)
CN111601825A (zh) 全人源的抗b细胞成熟抗原(bcma)单链抗体及其应用
NO20085362L (no) Hoyaffinitets humane og humaniserte anti-alfa5 beta1-integrin funksjonsblokkerende antistoffer med redusert immunogenisitet
JP2018537415A5 (https=)
JP2008514618A5 (https=)
JP2007525465A5 (https=)
JP2011184466A5 (https=)
EP2336174A3 (en) Human monoclonal antibodies against Hendra and Nipah viruses
JP2015212284A5 (https=)
CN111542546A (zh) 抗lag-3 抗体及其用途
BRPI0617485B8 (pt) anticorpo anti-il-13 humano isolado, composição farmacêutica e uso do referido anticorpo
JP2017226690A5 (https=)
WO2014194302A3 (en) Antigen binding proteins that bind pd-1
JP2018526970A5 (https=)
HRP20230197T1 (hr) Nosači za dostavu izvedeni iz omotača adenovirusnog proteina
CN114650845A (zh) 抗密蛋白抗体药物偶联物及其医药用途
WO2009074634A3 (en) Polypeptides, antibody variable domains & antagonists
EA201270813A1 (ru) АНТИТЕЛА К N3pGlu БЕТА-АМИЛОИДНОМУ ПЕПТИДУ И ИХ ПРИМЕНЕНИЕ
JP2011501176A5 (https=)
EP2399936A3 (en) Anti-CD154 antibodies
JP2008508859A5 (https=)
WO2011002968A3 (en) Polypeptides and method of treatment
MY146664A (en) Antibodies against human il-22 and uses therefor
WO2010018378A3 (en) Vaccine comprising amb 1 a peptides for use in the treatment of ragweed allergy